Association of albumin to non-high-density lipoprotein cholesterol ratio with mortality in peritoneal dialysis patients
Open Access
- 9 January 2024
- journal article
- research article
- Published by Taylor & Francis in Renal Failure
- Vol. 46 (1) , 2299601
Abstract
Malnutrition and inflammation are associated with mortality in peritoneal dialysis (PD) patients. Serum albumin and non-high-density lipoprotein cholesterol (non-HDL-C) are independently associated with mortality in PD patients. Combining albumin and non-HDL-C with mortality may be more plausible in clinical practice. This retrospective cohort study included 1954 Chinese PD patients from 1 January 2009 to 31 December 2016. Kaplan-Meier curve was used to determine the relationship between albumin to non-HDL-C ratio and all-cause mortality. Cox regression analysis was applied to assess the independent predictive value while adjusting for confounding factors. Competitive risk analysis was used to examine the effects of other outcomes on all-cause mortality prognosis. In the 33-month follow-up period, there were 538 all-cause deaths. Kaplan-Meier analysis presented significant differences in all-cause mortality. Multivariate Cox regression showed that the risk of all-cause mortality was lower in the moderate group (9.36-12.79) (HR, 0.731; 95% CI, 0.593-0.902, p = 0.004) and the highest group (>12.79) (HR, 0.705; 95% CI, 0.565-0.879, p = 0.002) compared to the lowest group (≤9.36). Competitive risk analysis revealed significant differences for all-cause mortality (p < 0.001), while there was no statistical significance for other competing events. Low albumin to non-HDL-C ratio was associated with a high risk of all-cause mortality in PD patients. It may serve as a potential prognostic biomarker in PD patients.Keywords
This publication has 47 references indexed in Scilit:
- Prevalence of chronic kidney disease in China: a cross-sectional surveyThe Lancet, 2012
- Serum Albumin as a Predictor of Mortality in Peritoneal Dialysis: Comparisons With HemodialysisAmerican Journal of Kidney Diseases, 2011
- MALNUTRITION‐INFLAMMATION‐ATHEROSCLEROSIS SYNDROME IN PATIENTS WITH END‐STAGE RENAL DISEASEJournal of Renal Care, 2011
- Malnutrition-Inflammation Score Independently Determined Cardiovascular and Infection Risk in Peritoneal Dialysis PatientsBlood Purification, 2010
- HMG CoA reductase inhibitors (statins) for dialysis patients2009
- Effect of ezetimibe/simvastatin vs atorvastatin on lowering levels of LDL-C and non–HDL-C, ApoB, and hs-CRP in patients with type 2 diabetesJournal of Clinical Lipidology, 2008
- Peritoneal Transport Status Influence on Atherosclerosis/Inflammation in CAPD PatientsJournal of Renal Nutrition, 2005
- Effects of atorvastatin and vitamin E on lipoproteins and oxidative stress in dialysis patients: a randomised‐controlled trialJournal of Internal Medicine, 2005
- POOR NUTRITIONAL STATUS AND INFLAMMATION: Serum Albumin: Relationship to Inflammation and NutritionSeminars in Dialysis, 2004
- A placebo-controlled trial examining atorvastatin in dyslipidemic patients undergoing CAPDKidney International, 2002